Sensei Biotherapeutics Announces Pricing of Upsized Initial Public Offering
03 févr. 2021 20h44 HE
|
Sensei Biotherapeutics
BOSTON and ROCKVILLE, Md., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation...